<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Gordon, Oliver</dc:creator>
  <dc:creator>Slenters, Tünde Vig</dc:creator>
  <dc:creator>Brunetto, Priscilla S.</dc:creator>
  <dc:creator>Villaruz, Amer E.</dc:creator>
  <dc:creator>Sturdevant, Daniel E.</dc:creator>
  <dc:creator>Otto, Michael</dc:creator>
  <dc:creator>Landmann, Regine</dc:creator>
  <dc:creator>Fromm, Katharina M.</dc:creator>
  <dc:date>2010-07-26</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Prosthetic joint replacements are used increasingly to alleviate pain and improve  mobility of the progressively older and more obese population. Implant infection  occurs in about 5% of patients and entails significant morbidity and high social costs.  It is most often caused by staphylococci, which are introduced perioperatively. They  are a source of prolonged seeding and difficult to treat due to antibiotic resistance;  therefore, infection prevention by prosthesis coating with nonantibiotic-type anti- infective substances is indicated. A renewed interest in topically used silver has  fostered development of silver nanoparticles, which, however, present a potential  health hazard. Here we present new silver coordination polymer networks with tailored  physical and chemical properties as nanostructured coatings on metallic implant  substrates. These compounds exhibited strong biofilm sugar-independent bactericidal  activity on in vitro-grown biofilms and prevented murine Staphylococcus epidermidis  implant infection in vivo with slow release of silver ions and limited transient leukocyte  cytotoxicity. Furthermore, we describe the biochemical and molecular mechanisms of  silver ion action by gene screening and by targeting cell metabolism of S. epidermidis  at different levels. We demonstrate that silver ions inactivate enzymes by binding  sulfhydryl (thiol) groups in amino acids and promote the release of iron with  subsequent hydroxyl radical formation by an indirect mechanism likely mediated by  reactive oxygen species. This is the first report investigating the global metabolic  effects of silver in the context of a therapeutic application. We anticipate that the  compounds presented here open a new treatment field with a high medical impact.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/301776</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/301776/files/fro_scp.pdf</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/301776/files/fro_scp_sm.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1128/AAC.01830-09</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Antimicrobial Agents and Chemotherapy. - 2010, vol. 54, no. 10, p. 4208-4218</dc:source>
  <dc:subject>info:eu-repo/classification/udc/54</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Silver coordination polymers for prevention of implant infection: thiol interaction, impact on respiratory chain enzymes, and hydroxyl radical induction</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
